LRRC37A2, leucine rich repeat containing 37 member A2, 474170
N. diseases: 7; N. variants: 70
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.160 | 17 | 46710944 | intron variant | G/A | snv | 0.28 | 0.30 |
|
Nervous System Diseases | 0.800 | 1.000 | 4 | 2009 | 2012 | ||||||
|
0.925 | 0.120 | 17 | 46751565 | synonymous variant | G/A | snv | 0.13 | 0.13 |
|
Nervous System Diseases | 0.800 | 1.000 | 4 | 2009 | 2012 | ||||||
|
1.000 | 0.040 | 17 | 46781778 | intron variant | C/T | snv | 0.84 |
|
Nervous System Diseases | 0.800 | 1.000 | 2 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 17 | 46935905 | 3 prime UTR variant | T/C | snv | 9.2E-02 |
|
0.800 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.882 | 0.160 | 17 | 46710944 | intron variant | G/A | snv | 0.28 | 0.30 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.925 | 0.120 | 17 | 46788237 | intron variant | T/C;G | snv |
|
Nervous System Diseases | 0.800 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.120 | 17 | 46779275 | intron variant | G/C | snv | 0.84 |
|
Nervous System Diseases | 0.800 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.120 | 17 | 46788073 | intron variant | T/G | snv | 0.27 |
|
Digestive System Diseases; Nutritional and Metabolic Diseases | 0.800 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.120 | 17 | 46935122 | missense variant | G/T | snv | 6.0E-05 | 8.4E-05 |
|
0.800 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 17 | 46935905 | 3 prime UTR variant | T/C | snv | 9.2E-02 |
|
0.700 | 1.000 | 7 | 2011 | 2019 | ||||||||
|
0.925 | 0.160 | 17 | 46712837 | intron variant | A/G | snv | 0.13 |
|
Nervous System Diseases | 0.700 | 1.000 | 3 | 2009 | 2012 | |||||||
|
0.882 | 0.160 | 17 | 46722680 | intron variant | G/A | snv | 0.59 |
|
Nervous System Diseases | 0.700 | 1.000 | 3 | 2009 | 2012 | |||||||
|
1.000 | 0.040 | 17 | 46935905 | 3 prime UTR variant | T/C | snv | 9.2E-02 |
|
0.700 | 1.000 | 2 | 2011 | 2016 | ||||||||
|
17 | 46785767 | intron variant | T/C | snv | 0.19 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 2 | 2017 | 2019 | |||||||||
|
17 | 46928746 | intron variant | C/G | snv | 0.54 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
17 | 46918168 | intron variant | C/T | snv | 0.52 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.040 | 17 | 46932200 | splice donor variant | G/A | snv | 1.0E-04 | 2.6E-04 |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
|
17 | 46852662 | intron variant | C/T | snv | 8.1E-03 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
17 | 46717868 | intron variant | A/G | snv | 0.30 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
17 | 46546423 | intron variant | T/A;C;G | snv | 0.51 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.080 | 17 | 46797087 | intron variant | C/T | snv | 0.11 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 17 | 46935027 | splice acceptor variant | A/G | snv |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.925 | 0.160 | 17 | 46712837 | intron variant | A/G | snv | 0.13 |
|
Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.160 | 17 | 46712837 | intron variant | A/G | snv | 0.13 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.040 | 17 | 46935905 | 3 prime UTR variant | T/C | snv | 9.2E-02 |
|
0.700 | 1.000 | 1 | 2011 | 2011 |